Concepta (CPT) Hits New 1-Year Low at $6.02
Concepta PLC (LON:CPT) shares hit a new 52-week low on Tuesday . The company traded as low as GBX 6.02 ($0.08) and last traded at GBX 6.25 ($0.09), with a volume of 197396 shares changing hands. The stock had previously closed at GBX 6.28 ($0.09).
Separately, Beaufort Securities reiterated a “speculative buy” rating on shares of Concepta in a report on Friday, December 15th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of GBX 484.30 ($6.69).
In other news, insider Erik Henau bought 100,000 shares of Concepta stock in a transaction that occurred on Thursday, November 30th. The shares were purchased at an average price of GBX 8 ($0.11) per share, for a total transaction of £8,000 ($11,052.78).
ILLEGAL ACTIVITY WARNING: This news story was published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://theolympiareport.com/2018/02/13/concepta-cpt-hits-new-1-year-low-at-6-02.html.
Concepta Company Profile
Concepta PLC, formerly Frontier Resources International Plc, is a healthcare company. The Company is involved in the development of products and a platform, which targets the personalized mobile health market with a focus on women’s fertility and unexplained infertility. The Company’s portfolio of products includes MyLotus Meter, Ovulation Test, Pregnancy Test and Fertility App.
Receive News & Ratings for Concepta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concepta and related companies with MarketBeat.com's FREE daily email newsletter.